<DOC>
	<DOCNO>NCT00361153</DOCNO>
	<brief_summary>This study design test whether WelChol ( colesevelam HC1 ) improve blood sugar control patient type 2 diabetes make insulin work efficiently .</brief_summary>
	<brief_title>Effects Colesevelam HC1 ( WelChol® ) Insulin Sensitivity Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Single-center , randomize , parallel , double-blind , placebo control , 8-week trial subject type 2 diabetes mellitus . Two parallel treatment group include double-blind colesevelam placebo . A screening period may 18 week withdraw non sulfonylurea antidiabetic treatment withdraw adjust sulfonylurea antidiabetic treatment . To evaluate hepatic peripheral insulin sensitivity , subject undergo two-step hyperinsulinemic-euglycemic clamp tritiated glucose infusion pre randomization 8 week treatment . To evaluate oral glucose absorption , subject undergo two oral glucose tolerance test ( OGTT ) pre randomization , one without colesevelam one colesevelam , one OGTT end treatment period..</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>Subjects meet follow criterion Screening Visit eligible participate trial : Have give write informed consent Ages 18 75 year , inclusive Diagnosis type 2 diabetes mellitus least 3 month duration HbA1C 7.0 10.0 % , inclusive Antidiabetic treatment may include oral agent ; antidiabetic agent must withdraw randomization Women may enrol pregnant ( negative serum βHCG Screening Visit ) , breastfeed , plan become pregnant trial . In addition , must either hysterectomy tubal ligation least 6 month sign informed consent , postmenopausal 1 year , practice acceptable method birth control . An acceptable method birth control may oral , injectable implantable hormonal contraceptive , intrauterine device , diaphragm plus spermicide , female condom plus spermicide . Abstinence , partner 's use condom , partner 's vasectomy NOT acceptable method contraception BMI 25 45 kg/M sq , inclusive Subjects exclude participation study follow criterion apply : Type 1 diabetes mellitus history diabetic ketoacidosis Treatment lipid blood pressure lower therapy stable three month randomization Treatment WelChol , cholestyramine colestipol hyperlipidemia within last 3 month Treatment thiazolidinediones History dysphagia , swallow disorder , intestinal motility disorder Serum triglyceride &gt; 500 mg/dL Visit 1 Serum LDLC &lt; 60 mg/dL Visit 1 Any condition therapy , opinion investigator , pose risk subject make participation subject 's best interest Use investigational drug within 30 day randomization Chronic treatment oral corticosteroid History hyperthyroidism and/or treatment thyroid hormone/ levothyroxine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>